Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Enalpa 60mg Prefilled Syringe

Prescription Icon
Prescription Required

Marketer

Bennet Pharmaceuticals Limited

Salt Composition

Enoxaparin (60mg)

Overview Enalpa 60mg Prefilled Syringe

Enoxaparin 60mg prefilled syringe is an anticoagulant medication employed to prevent and manage potentially dangerous blood clots. Its action inhibits the growth of existing clots and suppresses the development of new ones. This medication is also indicated for the prophylaxis of venous thromboembolism, encompassing deep vein thrombosis and pulmonary embolism. Administration is subcutaneous, performed by a healthcare professional; intramuscular injection is contraindicated. Dosage and treatment duration are individualized, factoring in your medical history, treatment goals, response to therapy, age, and weight. Continuous use is crucial, even in the absence of noticeable symptoms, as it provides ongoing protection against clot formation; discontinuation may lead to clot development. Activities that elevate bleeding or injury risk should be avoided during treatment. Commonly reported adverse effects include injection site discomfort, bleeding episodes, cephalalgia, thrombocytosis, respiratory difficulties, edema, anemia, pyrexia, diarrhea, and elevated hepatic enzymes. Severe headache may signify intracranial hemorrhage, while intense abdominal pain could suggest gastrointestinal bleeding. Bleeding complications, which may be subtle, warrant prompt medical attention. Report any concerning symptoms immediately. Prior to commencing treatment, disclose any pre-existing conditions, such as hypertension, diabetes mellitus, or recent cerebrovascular accident, to your physician. The medication is contraindicated in patients with active bleeding. Potential drug interactions exist; therefore, inform your doctor of all concurrently used medications to ensure compatibility. Individuals with low body weight may experience heightened bleeding susceptibility; alcohol consumption further increases the risk of gastrointestinal hemorrhage.

Primary Ingredients of Enalpa 60mg Prefilled Syringe

The information is unavailable.

Uses of Enalpa 60mg Prefilled Syringe

Managing and averting blood clot formation

Major Benefits of Enalpa 60mg Prefilled Syringe:

This device will administer your medication; your doctor, nurse, or caregiver will provide instruction on its home use.

Common Side effects of Enalpa 60mg Prefilled Syringe:

  • Bleeding
  • Headache
  • Low blood platelets
  • Increased liver enzymes
  • Anemia (low number of red blood cells)
  • Fever
  • Injection site pain
  • Breathing problems
  • Edema (swelling)
  • Diarrhea

How to use Enalpa 60mg Prefilled Syringe:

Your healthcare provider will administer medication using this apparatus. Home use instruction may be provided to you or your caregiver.

How Enalpa 60mg Prefilled Syringe works:

Each Enalpa 60mg pre-filled syringe contains an anticoagulant medication that neutralizes specific clotting factors in the blood. This action inhibits clot development, thus averting potential blockages within the body's circulatory system.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Enalpa 60mg Prefilled Syringe is of uncertain safety. Seek medical advice before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Enalpa 60mg Prefilled Syringes during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The use of Enalpa 60mg Prefilled Syringes during breastfeeding is likely safe. Available data from humans indicates minimal risk to the infant. The drug's transfer into breast milk is low, resulting in negligible quantities reaching the baby, posing no anticipated harm.

DrivingDrivingSAFE

Driving ability is typically unaffected by a single 60mg dose of Enalpa administered via prefilled syringe.

KidneyKidneyCAUTION

Patients with kidney impairment should use the Enalpa 60mg prefilled syringe cautiously. Dosage modification for this medication may be necessary. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Enalpa 60mg Prefilled Syringe administration to individuals with hepatic impairment. Physician consultation is recommended. Exercise prudence when prescribing to patients with pre-existing liver conditions.

What if you forget to take Enalpa 60mg Prefilled Syringe :

Should you forget a dose of your Enalpa 60mg pre-filled syringe, seek advice from your physician.

Facts to Know About Enalpa 60mg Prefilled Syringe

LabelValue
Type of Compound Low-molecular-weight heparin (LMWH)
Potential for Dependence None.
Type of Medication Hematological
Mechanism of Action Low-molecular-weight heparin (LMWH)

FAQs on Enalpa 60mg Prefilled Syringe

A subcutaneous injection of Enalpa 60mg, administered via a prefilled syringe, requires precise dosage. Pinch a stomach skin fold between thumb and finger. Following area cleansing, hold the syringe like a pencil; insert the needle fully into the fold. Completely inject the medication and dispose of the syringe according to your doctor's directions. Adhere strictly to your healthcare provider's instructions. Report any uncertainties or adverse reactions to your physician immediately.
Before commencing Enalpa 60mg Prefilled Syringe treatment, provide your physician with a complete medical history. Disclose any pre-existing conditions, including heart valve implants, peptic ulcers, hypertension, diabetes mellitus, or renal impairment. Prior reactions to heparin, or recent cerebrovascular events, neurosurgery, or spinal surgery should also be reported. These conditions may elevate the risk of adverse events. Adherence to your doctor's prescribed regimen is crucial.
Keep Enalpa 60mg pre-filled syringes at 25°C; freezing is prohibited. Multi-dose vials are stable for a maximum of 28 days post-first use. Dispose of the injection if cloudiness, discoloration, or syringe damage is observed. Consult the patient information leaflet prior to administration; seek pharmacist advice if uncertain.
Enalpa 60mg pre-filled syringes are administered in the management of chest pain and myocardial infarction following initial standard care. This medication is co-administered with other antiplatelet agents, such as aspirin. Its anticoagulant properties inhibit blood clot formation, thus mitigating the risk of recurrent events and complications.
Air bubbles in the syringe should be expelled into the injection site. Failure to do so results in medication loss and an inaccurate dosage.
Enalpa 60mg Prefilled Syr...
579
MRP 705
17% off